BRAF fusion
Showing 51 - 75 of 1,985
BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer
Recruiting
- Metastatic Non-small Cell Lung Cancer
- BRAF V600 Mutation
-
Lyon, Rhône Alpes, FranceCHU Lyon - Hôpital Cardio-Vasculaire et Pneumologique Louis Prad
Sep 14, 2022
Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)
Recruiting
- Melanoma (Skin)
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022
Learn More About NTRK Gene Fusion Positive in Solid Tumor in
Not yet recruiting
- Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
- No Drug
-
Multiple Locations, JapanMany Locations
Mar 20, 2023
Advanced Solid Tumor, BRAF V600 Mutation Trial in United States (ABM-1310, Cobimetinib)
Recruiting
- Advanced Solid Tumor
- BRAF V600 Mutation
-
San Francisco, California
- +3 more
Dec 30, 2022
First Line Treatment for BRAFV600E Mutant Metastatic Colorectal
Completed
- BRAF V600E Mutation Positive
- Metastatic Colorectal Cancer
- Non Interventional study
-
St. Veit/Glan, Austria
- +33 more
Jan 20, 2023
Degenerative Disc Disease, Spondylolisthesis Trial in Worcester (NanoBone)
Recruiting
- Degenerative Disc Disease
- Spondylolisthesis
- NanoBone
-
Worcester, MassachusettsUMass Memorial Health Care
Jan 30, 2023
Pelvic Fixation and Fusion During Multilevel Spinal Surgery
Not yet recruiting
- Spinal Fusion
- Deformity of Spine
- iFuse Bedrock Granite Implant System
- (no location specified)
Nov 28, 2022
Pain, Postoperative, Opioid Use, Lumbar Spine Injury Trial in Dallas (Sparrow Ascent Transcutaneous Auricular Neurostimulation
Not yet recruiting
- Pain, Postoperative
- +2 more
- Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN)
- Sham Control Device
-
Dallas, TexasUT Southwestern Medical Center
Oct 20, 2023
Lumbar Degenerative Disease Trial in Jinan (Non-fusion group, Fusion group)
Enrolling by invitation
- Lumbar Degenerative Disease
- Non-fusion group
- Fusion group
-
Jinan, Shandong, China
- +1 more
Oct 4, 2023
Atlantoaxial Dislocation Trial (Intra-articular Cages)
Not yet recruiting
- Atlantoaxial Dislocation
- Intra-articular Cages
- (no location specified)
Aug 20, 2023
Glioblastoma Trial in Beijing (PLB1001, Temozolomide, Cisplatin combined with Etoposide)
Active, not recruiting
- Glioblastoma
- PLB1001
- +2 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital,Capital Medical University
Oct 27, 2023
Cancer Harboring BRAF Alterations Trial (FORE8394, Cobicistat)
Not yet recruiting
- Cancer Harboring BRAF Alterations
- (no location specified)
Aug 15, 2022
for Surgical Treatment of Irreducible Atlantoaxial Dislocation
Not yet recruiting
- Atlantoaxial Dislocation
- Posterior intra-articular distraction and fusion
- +2 more
- (no location specified)
Jul 30, 2023
Colo-rectal Cancer Trial (biological, drug, procedure)
Not yet recruiting
- Colo-rectal Cancer
- Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
- +8 more
- (no location specified)
Aug 28, 2023
Juvenile; Scoliosis, Scoliosis Idiopathic, Scoliosis; Adolescence Trial in Palo Alto (Melatonin, Syrup)
Not yet recruiting
- Juvenile; Scoliosis
- +5 more
- Melatonin
- Syrup
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Oct 16, 2023
Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and
Recruiting
- Unresectable Colon Cancer Peritoneal Metastases
- PMMR/Ras/BRAF Wild-type
- Serplulimab Combined With FOLFIRI and Bevacizumab
-
Huzhou, Zhejiang, ChinaChangxing County People's Hospital
Feb 14, 2023
Sacroiliac Joint Dysfunction, Sacroiliac; Fusion, Sacroiliac Disorder Trial in Santa Monica, Lancaster (Use of iFuse TORQ)
Recruiting
- Sacroiliac Joint Dysfunction
- +3 more
- Use of iFuse TORQ
-
Santa Monica, California
- +1 more
May 12, 2023
Osteo Match Cages Versus PEEK Cages in Osteoporotic Patients
Enrolling by invitation
- Osteoporosis
- +2 more
-
Beijing, Beijing, ChinaPeking University Third Hospital
Aug 1, 2023
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as
Completed
- Colorectal Cancer Metastatic
- Targeted agent
- (no location specified)
Aug 31, 2023
Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab + Envafolimab + mFOLFOXIRI
- Cetuximab + mFOLFOX6/FOLFIRI
- (no location specified)
Jul 24, 2023
Safety of the FACET FIXation Implant.
Not yet recruiting
- Degenerative Lumbar Spinal Stenosis
- Surgery with FACET FIXATION implants
- Surgery with Pedicle Screw
- (no location specified)
Dec 1, 2022
Cancer, Malignancy, Neoplasia Trial in United States (ASN007: ascending doses, ASN007 RD)
Completed
- Cancer
- +18 more
- ASN007: ascending doses
- ASN007 RD
-
Tampa, Florida
- +4 more
Jul 7, 2020